Browse Our Resources
Report
Rates of opioid use, dependence, and overdose in the United States are reaching epidemic-level proportions. In this action plan, DPA outlines a robust response focused on effective treatment, harm reduction, prevention… Read More
Report
The Drug Policy Alliance (DPA) recommends providing youth with honest, comprehensive drug education focused on empowering them to assess risky situations and make choices that reduce potential harm. Research by… Read More
Sign-on Letter
This letter signed by nearly 50 civil rights, faith, and criminal justice organizations was sent to the U.S. House opposing a bill intended to give states more flexibility to impose drug testing as a condition of… Read More
On November 8, 2016, California voters passed Proposition 64 (“Prop. 64”) into law. Prop. 64 legalizes the possession, transport, purchase, consumption and sharing of up to one ounce of marijuana and up to eight grams… Read More
Fact Sheet
Overview
Supervised consumption services (SCS) are legally sanctioned facilities designed to reduce the health and public order issues often associated with public injection. They are also called safer injection… Read More
Fact Sheet
Research simply does not support the theory that marijuana is a “gateway” drug – that is, one whose use results in an increased likelihood of using “more serious” drugs such as cocaine… Read More
Listen to the teleconference.
Representatives from a broad spectrum of organizations offered their reactions to Senator Sessions’ responses during his confirmation hearings this week to questions on criminal… Read More
Fact Sheet
Lysergic acid diethylamide, commonly referred to as LSD, or “acid,” is considered the best known and most researched psychedelic drug. This fact sheet provides answers to some of the most commonly-asked… Read More
Fact Sheet
Psilocybin is the main ingredient found in several types of psychoactive mushrooms, making it perhaps the best-known naturally-occurring psychedelic drug. This fact sheet provides answers to some of the most… Read More
The Ally is the Drug Policy Alliance's member newsletter. We love to hear from our members – if you have questions or feedback, contact The Ally at newsletter@drugpolicy.org.